Femtech startup Inne takes the wraps off a hormone tracker and $8.8M in funding
Post date: 2019-10-31 20:00:45
Views: 291
Berlin-based femtech startup Inne is coming out of stealth to announce an €8 million (~$8.8M) Series A and give the first glimpse of a hormone-tracking subscription product for fertility-tracking and natural contraception that’s slated for launch in Q1 next year. The Series A is led by led by Blossom Capital, with early Inne backer Monkfish
Please click Here to read the full story.
 
Other Top and Latest Questions:
Starbucks turnaround will take time. This options strategy works if shares remain range-bound
A look at two industrial names on our Best Stocks list, including one that's a buy right now
Mortgage rewards credit cards are disappearing. Here's what to do next
Why the 2025 stock market rally can continue in 2026, according to UBS
Trump's 'no tax on tips' deduction won't benefit some tipped workers. Here's why
Limitation on changing of usernames
It's too late for some last-minute tax moves — but these can be tackled with days to go in 2025
A rotation into value stocks from growth could grow stronger in the new year
Amazon faces 'leader's dilemma' — fight AI shopping bots or join them
Flash flooding in northern California leads to soaked roads, water rescues and one death